Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Integrating Obesity Treatment Into Routine Primary Care.

Tsai AG.

Ann Intern Med. 2019 Nov 12. doi: 10.7326/M19-2988. [Epub ahead of print] No abstract available.

PMID:
31711100
2.

Response by Lundberg et al to Letter Regarding Article, "Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell".

Lundberg JO, Cabrales P, Tsai AG, Patel RP, Kim-Shapiro DB.

Circulation. 2019 Nov 5;140(19):e760-e761. doi: 10.1161/CIRCULATIONAHA.119.043151. Epub 2019 Nov 4. No abstract available.

PMID:
31682526
3.

A Protocol to Deliver Intensive Behavioral Therapy (IBT) for Obesity in Primary Care Settings: The MODEL-IBT Program.

Wadden TA, Tsai AG, Tronieri JS.

Obesity (Silver Spring). 2019 Oct;27(10):1562-1566. doi: 10.1002/oby.22594. Review.

PMID:
31544345
4.

A Toolbox Approach to Obesity Treatment in Urban Safety-Net Primary Care Clinics: a Pragmatic Clinical Trial.

Saxon DR, Chaussee EL, Juarez-Colunga E, Tsai AG, Iwamoto SJ, Speer RB, Heyn H, Kealey EH, Bessesen DH.

J Gen Intern Med. 2019 Nov;34(11):2405-2413. doi: 10.1007/s11606-019-05222-0. Epub 2019 Aug 26.

PMID:
31485965
5.

Why I Treat Obesity.

Tsai AG.

Perm J. 2019;23. doi: 10.7812/TPP/18-240. Epub 2019 May 15.

6.

Return to Yoga Rates Are High After Volar Plating of Distal Radius Fractures.

Goyal N, Tsai AG, Li J, Wysocki RW.

Hand (N Y). 2019 May 23:1558944719850639. doi: 10.1177/1558944719850639. [Epub ahead of print]

PMID:
31122060
7.

Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell.

Sun CW, Yang J, Kleschyov AL, Zhuge Z, Carlström M, Pernow J, Wajih N, Isbell TS, Oh JY, Cabrales P, Tsai AG, Townes T, Kim-Shapiro DB, Patel RP, Lundberg JO.

Circulation. 2019 Jun 4;139(23):2654-2663. doi: 10.1161/CIRCULATIONAHA.118.039284. Epub 2019 Mar 25.

PMID:
30905171
8.

Primary Care Interventions for Obesity: Review of the Evidence.

Tronieri JS, Wadden TA, Chao AM, Tsai AG.

Curr Obes Rep. 2019 Jun;8(2):128-136. doi: 10.1007/s13679-019-00341-5. Review.

PMID:
30888632
9.

Weight Loss Interventions in Adults.

Tsai AG, Apovian C, Kaplan L.

JAMA. 2019 Mar 5;321(9):900. doi: 10.1001/jama.2018.20287. No abstract available.

PMID:
30835301
10.

Obesity.

Tsai AG, Bessesen DH.

Ann Intern Med. 2019 Mar 5;170(5):ITC33-ITC48. doi: 10.7326/AITC201903050.

PMID:
30831593
11.

A Mechanistic Analysis of Possible Blood Transfusion Failure to Increase Circulatory Oxygen Delivery in Anemic Patients.

Zimmerman RA, Tsai AG, Intaglietta M, Tartakovsky DM.

Ann Biomed Eng. 2019 Apr;47(4):1094-1105. doi: 10.1007/s10439-019-02200-9. Epub 2019 Jan 18.

PMID:
30659435
12.

Impact of somatic and germline mutations on the outcome of systemic mastocytosis.

Muñoz-González JI, Jara-Acevedo M, Alvarez-Twose I, Merker JD, Teodosio C, Hou Y, Henriques A, Roskin KM, Sanchez-Muñoz L, Tsai AG, Caldas C, Matito A, Sánchez-Gallego JI, Mayado A, Dasilva-Freire N, Gotlib JR, Escribano L, Orfao A, García-Montero AC.

Blood Adv. 2018 Nov 13;2(21):2814-2828. doi: 10.1182/bloodadvances.2018020628.

13.

Two-Year Results of Think Health! ¡Vive Saludable!: A Primary Care Weight-Management Trial.

Kumanyika SK, Morales KH, Allison KC, Russell Localio A, Sarwer DB, Phipps E, Fassbender JE, Tsai AG, Wadden TA.

Obesity (Silver Spring). 2018 Sep;26(9):1412-1421. doi: 10.1002/oby.22258. Epub 2018 Aug 29.

14.

Marijuana's Influence on Pain Scores, Initial Weight Loss, and Other Bariatric Surgical Outcomes.

Bauer FL, Donahoo WT, Hollis HW Jr, Tsai AG, Pottorf BJ, Johnson JM, Silveira LJ, Husain FA.

Perm J. 2018;22:18-002. doi: 10.7812/TPP/18-002.

15.

Differences in perspectives regarding diabetes management between health care providers and patients.

Loskutova NY, Tsai AG, Callen E, Ajayi K, Carroll JK, Harrington M, Turner TJ, Pace WD.

Transl Behav Med. 2018 May 23;8(3):328-340. doi: 10.1093/tbm/iby024.

PMID:
29800415
16.

The Science of Obesity Management: An Endocrine Society Scientific Statement.

Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, Hu FB, Jakicic JM, Ryan DH, Wolfe BM, Inge TH.

Endocr Rev. 2018 Apr 1;39(2):79-132. doi: 10.1210/er.2017-00253. Review.

17.

Evidence of a gap in understanding obesity among physicians.

Tsai AG, Histon T, Kyle TK, Rubenstein N, Donahoo WT.

Obes Sci Pract. 2018 Jan 12;4(1):46-51. doi: 10.1002/osp4.146. eCollection 2018 Feb.

18.

Treatment of Obesity in Primary Care.

Tsai AG, Remmert JE, Butryn ML, Wadden TA.

Med Clin North Am. 2018 Jan;102(1):35-47. doi: 10.1016/j.mcna.2017.08.005. Epub 2017 Oct 21. Review.

PMID:
29156186
20.

Losing Weight During the Postpartum Period.

Tsai AG, Nicholson WK.

JAMA. 2017 Jun 20;317(23):2375-2376. doi: 10.1001/jama.2017.7036. No abstract available.

PMID:
28632851
21.

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.

Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos CE, Arber DA, Verstovsek S, Orazi A.

Haematologica. 2017 Aug;102(8):1352-1360. doi: 10.3324/haematol.2017.165340. Epub 2017 May 11.

22.

Posttransfusion Increase of Hematocrit per se Does Not Improve Circulatory Oxygen Delivery due to Increased Blood Viscosity.

Zimmerman R, Tsai AG, Salazar Vázquez BY, Cabrales P, Hofmann A, Meier J, Shander A, Spahn DR, Friedman JM, Tartakovsky DM, Intaglietta M.

Anesth Analg. 2017 May;124(5):1547-1554. doi: 10.1213/ANE.0000000000002008.

23.

A System-Level Approach to Overweight and Obesity in the Veterans Health Administration.

Raffa SD, Maciejewski ML, Zimmerman LE, Damschroder LJ, Estabrooks PA, Ackermann RT, Tsai AG, Histon T, Goldstein MG.

J Gen Intern Med. 2017 Apr;32(Suppl 1):79-82. doi: 10.1007/s11606-016-3948-z.

24.

Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.

Martucci AF, Abreu Martucci AC, Cabrales P, Nascimento PD Jr, Intaglietta M, Tsai AG, Castiglia YM.

Artif Cells Nanomed Biotechnol. 2017 Feb;45(1):24-30. Epub 2016 Oct 31.

25.

Investing in Obesity Treatment: Kaiser Permanente's Approach to Chronic Disease Management.

Tsai AG, Histon T, Donahoo WT, Hashmi S, Murali S, Latare P, Oliver L, Slovis J, Grall S, Fisher D, Solomon L.

Curr Obes Rep. 2016 Sep;5(3):307-11. doi: 10.1007/s13679-016-0223-x. Review.

PMID:
27342446
26.

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.

Wang SA, Tam W, Tsai AG, Arber DA, Hasserjian RP, Geyer JT, George TI, Czuchlewski DR, Foucar K, Rogers HJ, Hsi ED, Bryan Rea B, Bagg A, Dal Cin P, Zhao C, Kelley TW, Verstovsek S, Bueso-Ramos C, Orazi A.

Mod Pathol. 2016 Aug;29(8):854-64. doi: 10.1038/modpathol.2016.75. Epub 2016 May 13.

27.

Impact of intensive lifestyle intervention on preference-based quality of life in type 2 diabetes: Results from the Look AHEAD trial.

Zhang P, Hire D, Espeland MA, Knowler WC, Thomas S, Tsai AG, Glick HA; Look AHEAD Research Group.

Obesity (Silver Spring). 2016 Apr;24(4):856-64. doi: 10.1002/oby.21445. Epub 2016 Mar 8.

28.

Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial.

Fischer HH, Fischer IP, Pereira RI, Furniss AL, Rozwadowski JM, Moore SL, Durfee MJ, Raghunath SG, Tsai AG, Havranek EP.

Diabetes Care. 2016 Aug;39(8):1364-70. doi: 10.2337/dc15-2137. Epub 2016 Feb 9.

PMID:
26861922
29.

Patient Navigators Connecting Patients to Community Resources to Improve Diabetes Outcomes.

Loskutova NY, Tsai AG, Fisher EB, LaCruz DM, Cherrington AL, Harrington TM, Turner TJ, Pace WD.

J Am Board Fam Med. 2016 Jan-Feb;29(1):78-89. doi: 10.3122/jabfm.2016.01.150048.

30.

A randomized clinical trial of a weight loss maintenance intervention in a primary care population.

Tsai AG, Felton S, Wadden TA, Hosokawa PW, Hill JO.

Obesity (Silver Spring). 2015 Oct;23(10):2015-21. doi: 10.1002/oby.21224. Epub 2015 Sep 3.

31.

Medication costs during an 18 month clinical trial of obesity treatment among patients encountered in primary care.

Tsai AG, Juarez-Colunga E, Felton S, Speer RB, Bessesen DH, Atherly AJ.

BMC Obes. 2015 May 29;2:24. doi: 10.1186/s40608-015-0054-4. eCollection 2015.

32.

Biomechanical evaluation of a novel suturing scheme for grafting load-bearing collagen scaffolds for rotator cuff repair.

Islam A, Bohl MS, Tsai AG, Younesi M, Gillespie R, Akkus O.

Clin Biomech (Bristol, Avon). 2015 Aug;30(7):669-75. doi: 10.1016/j.clinbiomech.2015.05.007. Epub 2015 May 16.

33.

Reversible biological adaptations in obesity - Authors' reply.

Ochner CN, Tsai AG, Kushner RF, Wadden TA.

Lancet Diabetes Endocrinol. 2015 May;3(5):314-5. doi: 10.1016/S2213-8587(15)00091-1. No abstract available.

PMID:
25943750
34.

Supra-plasma expanders: the future of treating blood loss and anemia without red cell transfusions?

Tsai AG, Vázquez BY, Hofmann A, Acharya SA, Intaglietta M.

J Infus Nurs. 2015 May-Jun;38(3):217-22. doi: 10.1097/NAN.0000000000000103. Review.

35.

Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations.

Ochner CN, Tsai AG, Kushner RF, Wadden TA.

Lancet Diabetes Endocrinol. 2015 Apr;3(4):232-4. doi: 10.1016/S2213-8587(15)00009-1. Epub 2015 Feb 12. No abstract available.

PMID:
25682354
36.

Human lymphoid translocation fragile zones are hypomethylated and have accessible chromatin.

Lu Z, Lieber MR, Tsai AG, Pardo CE, Müschen M, Kladde MP, Hsieh CL.

Mol Cell Biol. 2015 Apr;35(7):1209-22. doi: 10.1128/MCB.01085-14. Epub 2015 Jan 26.

37.

Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Mooij HL, Cabrales P, Bernelot Moens SJ, Xu D, Udayappan SD, Tsai AG, van der Sande MA, de Groot E, Intaglietta M, Kastelein JJ, Dallinga-Thie GM, Esko JD, Stroes ES, Nieuwdorp M.

J Am Heart Assoc. 2014 Dec 2;3(6):e001274. doi: 10.1161/JAHA.114.001274.

38.

Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review.

Wadden TA, Butryn ML, Hong PS, Tsai AG.

JAMA. 2014 Nov 5;312(17):1779-91. doi: 10.1001/jama.2014.14173. Review.

39.

Replacing the Transfusion of 1-2 Units of Blood with Plasma Expanders that Increase Oxygen Delivery Capacity: Evidence from Experimental Studies.

Tsai AG, Salazar Vázquez BY, Cabrales P, Kistler EB, Tartakovsky DM, Subramaniam S, Acharya SA, Intaglietta M.

J Funct Biomater. 2014 Oct 27;5(4):232-45. doi: 10.3390/jfb5040232. Review.

40.
41.

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Sep;37(9):2548-56. doi: 10.2337/dc14-0093.

42.

Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia.

Tsai AG, Cabrales P, Young MA, Winslow RM, Intaglietta M.

Artif Cells Nanomed Biotechnol. 2015 Feb;43(1):10-7. doi: 10.3109/21691401.2014.936063. Epub 2014 Jul 25.

PMID:
25060721
43.

PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs.

Meng F, Tsai AG, Intaglietta M, Acharya SA.

Artif Cells Nanomed Biotechnol. 2015;43(4):270-81. doi: 10.3109/21691401.2014.885443. Epub 2014 Mar 6.

44.

Frequency of laboratory testing among gastric bypass patients.

Tsai AG, Hosokawa P, Schoen J, Prochazka AV.

Surg Obes Relat Dis. 2014 Mar-Apr;10(2):340-5. doi: 10.1016/j.soard.2013.09.005. Epub 2013 Sep 23.

PMID:
24355327
45.

Obesity and serious infections.

Tsai AG, Wadden TA.

Ann Intern Med. 2013 Dec 17;159(12):859. doi: 10.7326/0003-4819-159-12-201312170-00022. No abstract available.

PMID:
24343401
46.

Readiness redefined: a behavioral task during screening predicted 1-year weight loss in the look AHEAD study.

Tsai AG, Fabricatore AN, Wadden TA, Higginbotham AJ, Anderson A, Foreyt J, Hill JO, Jeffery RW, Gluck ME, Lipkin EW, Reeves RS, Van Dorsten B.

Obesity (Silver Spring). 2014 Apr;22(4):1016-23. doi: 10.1002/oby.20648. Epub 2013 Dec 9.

47.

A fatigue loading model for investigation of iatrogenic subtrochanteric fractures of the femur.

Tsai AG, Reich MS, Bensusan J, Ashworth T, Marcus RE, Akkus O.

Clin Biomech (Bristol, Avon). 2013 Nov-Dec;28(9-10):981-7. doi: 10.1016/j.clinbiomech.2013.09.009. Epub 2013 Sep 25.

PMID:
24125692
48.

In the clinic: obesity.

Tsai AG, Wadden TA.

Ann Intern Med. 2013 Sep 3;159(5):ITC3-1-ITC3-15; quiz ITC3-16. doi: 10.7326/0003-4819-159-5-201309030-01003. Review. No abstract available.

PMID:
24026335
49.

Effects of fibrinogen concentrate after shock/resuscitation: a comparison between in vivo microvascular clot formation and thromboelastometry*.

Martini J, Cabrales P, Fries D, Intaglietta M, Tsai AG.

Crit Care Med. 2013 Nov;41(11):e301-8. doi: 10.1097/CCM.0b013e31828a4520.

50.

Cost-effectiveness of a primary care intervention to treat obesity.

Tsai AG, Wadden TA, Volger S, Sarwer DB, Vetter M, Kumanyika S, Berkowitz RI, Diewald LK, Perez J, Lavenberg J, Panigrahi ER, Glick HA.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S31-7. doi: 10.1038/ijo.2013.94.

Supplemental Content

Support Center